Shauna McGillivray

Professor & Associate Department Chair Texas Christian University

  • Fort Worth TX

Biology expert, focusing on genetic methods of fighting disease

Contact

Texas Christian University

View more experts managed by Texas Christian University

Spotlight

1 min

Expert Research: The Surprising Source of Next-Gen Antibiotics: Oyster Blood

Antimicrobial resistance (AMR) is a growing concern across the world and it has doctors worried and scientists working hard to find a solution Basically, AMR is when bacteria and viruses no longer respond to antimicrobial medicines. The result is making infections harder to treat and increases the risk of spreading disease. Recently, Texas Christian University researcher Shauna McGillivray commented on exciting new research in this area that was featured in the media: The search for a solution to antimicrobial resistance found something. And researchers found it in a true “it’s always the last place you look” location. Australian oysters. Or more specifically, Australian oyster blood. Antimicrobial proteins and peptides (AMPPs) “… are an exciting area with a lot of potential,” said Shauna McGillivray, professor of biology at TCU with an emphasis on host-pathogen interactions. “[They] are by themselves very potent but, as has been noted in multiple studies, they can also synergize with existing antibiotics, thereby improving efficacy of antibiotics, even in some cases to antibiotics to which there are high levels of resistance.” Feb. 22 -Phamed.com This is an amazing find and could be groundbreaking for the pharmaceutical industry and health care. And if you're looking to know more about this research and what it means for health care then let us help. Shauna McGillivray, associate professor of biology is available to speak with media about her recent research simply click on her icon now to arrange an interview today.

Shauna McGillivray

Media

Social

Biography

I have had a long-standing interest in understanding host-pathogen interactions, particularly between bacterial pathogens and the host innate immune system. In my lab, we use molecular and microbiological tools to identify and investigate the mechanism behind potential bacterial virulence genes. We primarily work with Bacillus anthracis, the causative agent of the deadly disease anthrax, as well as with the Staphylococcus aureus, the leading cause of skin and soft tissue infections. Currently, my lab studies a conserved intracellular bacterial protease called ClpXP and its role in virulence. Loss of ClpXP through genetic or pharmacological inhibition renders B. anthracis unable to survive in the host. One possible mechanism is due to increased susceptibility to antimicrobial peptides produced by the host innate immune system. The connection between ClpXP and bacterial defense against antimicrobial peptides is currently a major focus of investigation. My lab is also interested in the development of new antimicrobial agents. We are currently working in collaboration with Dr. Ken Keiler at Penn State University to investigate inhibiting trans-translation in S. aureus as a potential antibiotic target.

Areas of Expertise

Antibiotic Resistance
Microbiology
Intersections of Genetics and Disease
Bacterial Virulence in Genes
Bacterial Pathogenesis

Education

University of California, San Diego

PhD

Biology

2006

Concordia College

BSc

Biology

1999

Affiliations

  • American Society of Microbiology
  • Texas Association for Advisors of Health Professions

Media Appearances

Stopping Anthrax With Antibiotics

TCU Magazine  online

2018-06-21

Shauna McGillivray, associate professor of biology, figured out how to render the bacteria harmless in mammals by subverting one of the key enzymes that anthrax uses to create disease.

View More

A Culture Of Collaboration

TCU Endeavors  online

The TCU educational experience has long revolved around the teacher-scholar model, made possible by the 13:1 student-to-faculty ratio. Small class sizes lead to an environment conducive to the kind of mentorship necessary for effective integrated research teams. At many top 100 universities throughout the United States, only juniors and seniors do meaningful work in labs, and even then they’re often supervised by graduate students and have little to no contact with professors. Not so at TCU.

View More

Articles

Loss of the ClpXP Protease Leads to Decreased Resistance to Cell-Envelope Targeting Antimicrobials in Bacillus anthracis Sterne

Frontiers in Microbiology

2021

The ClpX ATPase is critical for resistance to cell envelope targeting antibiotics in Bacillus anthracis, however, it is unclear whether this is due to its function as an independent chaperone or as part of the ClpXP protease. In this study, we demonstrate that antibiotic resistance is due to formation of the ClpXP protease through construction of a ClpX complementation plasmid that is unable to interact with ClpP.

View more

Microscale ZnO with controllable crystal morphology as a platform to study antibacterial action on Staphylococcus aureus

Biointerphases

2021

Nano- and microcrystalline ZnO is an inexpensive, easily synthesized material with a multitude of applications. Its usefulness in the present and future stems from its exceptional optoelectronic, structural, and chemical characteristics as well as a broad range of production techniques. One application comes from its ability to inhibit bacterial growth. Despite the well-documented, vigorously studied antimicrobial action of ZnO particles, the most fundamental physical and chemical mechanisms driving growth inhibition are still not well identified.

View more

A Small Molecule Inhibitor of Trans -Translation Synergistically Interacts with Cathelicidin Antimicrobial Peptides to Impair Survival of Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

2019

Staphylococcus aureus is a leading cause of infection in the US and, due to the rapid development of resistance, new antibiotics are constantly needed. Trans -translation is a particularly promising antibiotic target because it is conserved in many bacterial species, is critical to bacterial survival, and is unique among prokaryotes. We have investigated the potential of KKL-40, a small molecule inhibitor of trans -translation, and find that it inhibits both methicillin-susceptible and methicillin-resistant strains of S. aureus . KKL-40 is also effective against Gram-positive pathogens including a vancomycin-resistant strain of Enterococcus faecalis , Bacillus subtilis and Streptococcus pyogenes , although its performance with Gram-negatives is mixed. KKL-40 synergistically interacts with the human antimicrobial peptide LL-37, a member of the cathelicidin family, to inhibit S . aureus but not other antibiotics tested including daptomycin, kanamycin or erythromycin. KKL-40 is not cytotoxic to HeLa cells at concentrations that are 100-fold greater than the effective MIC. We also find that S. aureus develops minimal resistance to KKL-40 even after multi-day passage in sub-lethal concentrations. Therefore, trans -translation inhibitors could be a particularly promising drug target against S. aureus , not only because of their ability to inhibit bacterial growth, but also because of their potential to simultaneously render S. aureus more susceptible to host antimicrobial peptides.

View more

Show All +